Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

Clinical trial NCT01684098 · COMPLETED

Trial details

NCT number: NCT01684098
Sponsor: Endocyte
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent or Metastatic Cancer Head and Neck Cancer Pancreas Cancer Bladder Cancer Testicular Cancer

Start date: 2003-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.